Journey Medical Corp
DERM- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001867066
No open-market purchases or sales by Journey Medical Corp insiders were filed in the last 90 days; 71 institutions reported holding it in 13F filings for Q2 2026, worth $75.2M in total; no superinvestor holds it.
Q3 2023 vs. Q2 2023
How the institutions holding Journey Medical Corp changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Of which not filed for Q3 2023 | Q3 2023 | Change |
|---|---|---|---|---|
| Holders | 20 | 1 | 21 | +2 |
| Shares | 1.65M | 2.00K | 2.14M | +484.4K (+29.3%) |
| Value | $2.63M | $3.18K | $5.85M | +$3.23M (+122.9%) |
1 institution that held it in Q2 2023 haven't filed for Q3 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (5)
Institutions that held Journey Medical Corp at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Tang Capital Management LLC | 576,100 | $1.58M | 0.22% |
| Millennium Management LLC | 14,462 | $39.6K | 0.00% |
| GWM Advisors LLC | 12,244 | $33.5K | 0.00% |
| State Street Corp | 11,853 | $32.5K | 0.00% |
| JPMorgan Chase & Co | 7 | $19 | 0.00% |
Sold out (3)
Institutions that held Journey Medical Corp at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| First Manhattan Co | 35,294 | $56.1K |
| National Asset Management, Inc. | 17,250 | $27.4K |
| Two Sigma Securities, LLC | 12,016 | $19.1K |
Not filed for Q3 2023 yet (1)
Institutions that held Journey Medical Corp at the end of Q2 2023 and haven't filed a 13F for Q3 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| BerganKDV Wealth Management, LLC | 2,000 | $3.18K |